268 related articles for article (PubMed ID: 37998740)
1. The Role of Epigenetic Modifier Mutations in Peripheral T-Cell Lymphomas.
Tigu AB; Bancos A
Curr Issues Mol Biol; 2023 Nov; 45(11):8974-8988. PubMed ID: 37998740
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas.
Yoon SE; Cho J; Kim YJ; Ko YH; Park WY; Kim SJ; Kim WS
Exp Hematol Oncol; 2021 May; 10(1):33. PubMed ID: 33990228
[TBL] [Abstract][Full Text] [Related]
3. Distinct and overlapping features of nodal peripheral T-cell lymphomas exhibiting a follicular helper T-cell phenotype: a multicenter study emphasizing the clinicopathological significance of follicular helper T-cell marker expression.
Paik JH; Koh J; Han B; Kim S; Lee KR; Lee S; Lee JO; Kim TM; Kim WY; Jeon YK
Hum Pathol; 2023 Jan; 131():47-60. PubMed ID: 36495942
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological implications of immunohistochemical expression of TBX21, CXCR3, GATA3, CCR4, and TCF1 in nodal follicular helper T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified.
Han B; Lim S; Yim J; Song YK; Koh J; Kim S; Lee C; Kim YA; Jeon YK
J Pathol Transl Med; 2024 Mar; 58(2):59-71. PubMed ID: 38247153
[TBL] [Abstract][Full Text] [Related]
5. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.
Lemonnier F; Couronné L; Parrens M; Jaïs JP; Travert M; Lamant L; Tournillac O; Rousset T; Fabiani B; Cairns RA; Mak T; Bastard C; Bernard OA; de Leval L; Gaulard P
Blood; 2012 Aug; 120(7):1466-9. PubMed ID: 22760778
[TBL] [Abstract][Full Text] [Related]
6. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
Yao WQ; Wu F; Zhang W; Chuang SS; Thompson JS; Chen Z; Zhang SW; Clipson A; Wang M; Liu H; Bibawi H; Huang Y; Campos L; Grant JW; Wright P; Ei-Daly H; Rásó-Barnett L; Farkas L; Follows GA; Gao Z; Attygalle AD; Ashton-Key M; Liu W; Du MQ
J Pathol; 2020 Mar; 250(3):346-357. PubMed ID: 31859368
[TBL] [Abstract][Full Text] [Related]
7. Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features.
Manso R; González-Rincón J; Rodríguez-Justo M; Roncador G; Gómez S; Sánchez-Beato M; Piris MA; Rodríguez-Pinilla SM
Oncotarget; 2018 Mar; 9(22):16124-16133. PubMed ID: 29662631
[TBL] [Abstract][Full Text] [Related]
8. BCL6 locus is hypermethylated in angioimmunoblastic T-cell lymphoma.
Nishizawa S; Sakata-Yanagimoto M; Hattori K; Muto H; Nguyen T; Izutsu K; Yoshida K; Ogawa S; Nakamura N; Chiba S
Int J Hematol; 2017 Apr; 105(4):465-469. PubMed ID: 27921272
[TBL] [Abstract][Full Text] [Related]
9. Large cell morphology, CMYC+ tumour cells, and PD-1+ tumour cell/intense PD-L1+ cell reactions are important prognostic factors in nodal peripheral T-cell lymphomas with T follicular helper markers.
Mihashi Y; Kimura S; Iwasaki H; Oshiro Y; Takamatsu Y; Kawauchi S; Shimajiri S; Ishizuka K; Takeshita M
Diagn Pathol; 2021 Nov; 16(1):101. PubMed ID: 34742294
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
[TBL] [Abstract][Full Text] [Related]
11. Management of Angioimmunoblastic T-Cell Lymphoma (AITL) and other T Follicular Helper Cell lymphomas (TFH PTCL).
Ma H; O'Connor OA; Marchi E
Semin Hematol; 2021 Apr; 58(2):95-102. PubMed ID: 33906727
[TBL] [Abstract][Full Text] [Related]
12. Peripheral T-cell lymphoma with follicular T-cell markers.
Rodríguez-Pinilla SM; Atienza L; Murillo C; Pérez-Rodríguez A; Montes-Moreno S; Roncador G; Pérez-Seoane C; Domínguez P; Camacho FI; Piris MA
Am J Surg Pathol; 2008 Dec; 32(12):1787-99. PubMed ID: 18779728
[TBL] [Abstract][Full Text] [Related]
13. Clonal hematopoiesis and bone marrow infiltration in patients with follicular helper T-cell lymphoma of angioimmunoblastic type.
Harland L; Borgmann V; Otto F; Overkamp M; Bonzheim I; Fend F; Quintanilla-Martinez L; Nann D
Mod Pathol; 2024 May; ():100519. PubMed ID: 38777036
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specified.
Kim S; Kwon D; Koh J; Nam SJ; Kim YA; Kim TM; Kim CW; Jeon YK
Virchows Arch; 2020 Jul; 477(1):131-142. PubMed ID: 32170448
[TBL] [Abstract][Full Text] [Related]
15. Biological insights into the role of TET2 in T cell lymphomas.
Carty SA
Front Oncol; 2023; 13():1199108. PubMed ID: 37841428
[TBL] [Abstract][Full Text] [Related]
16. Markers of Follicular Helper T Cells Are Occasionally Expressed in T-Cell or Histiocyte-Rich Large B-Cell Lymphoma, Classic Hodgkin Lymphoma, and Atypical Paracortical HyperplasiaA Diagnostic Pitfall For T-Cell Lymphomas of T Follicular Helper Origin.
Abukhiran I; Syrbu SI; Holman CJ
Am J Clin Pathol; 2021 Aug; 156(3):409-426. PubMed ID: 33624021
[TBL] [Abstract][Full Text] [Related]
17. T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma.
Ghione P; Faruque P; Mehta-Shah N; Seshan V; Ozkaya N; Bhaskar S; Yeung J; Spinner MA; Lunning M; Inghirami G; Moskowitz A; Galasso N; Ganesan N; van der Weyden C; Ruan J; Prince HM; Trotman J; Advani R; Dogan A; Horwitz S
Blood Adv; 2020 Oct; 4(19):4640-4647. PubMed ID: 33002132
[TBL] [Abstract][Full Text] [Related]
18. The pathological features of angioimmunoblastic T-cell lymphomas with IDH2
Steinhilber J; Mederake M; Bonzheim I; Serinsöz-Linke E; Müller I; Fallier-Becker P; Lemonnier F; Gaulard P; Fend F; Quintanilla-Martinez L
Mod Pathol; 2019 Jul; 32(8):1123-1134. PubMed ID: 30952970
[TBL] [Abstract][Full Text] [Related]
19. DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS.
Herek TA; Bouska A; Lone W; Sharma S; Amador C; Heavican TB; Li Y; Wei Q; Jochum D; Greiner TC; Smith L; Pileri S; Feldman AL; Rosenwald A; Ott G; Lim ST; Ong CK; Song J; Jaffe ES; Wang GG; Staudt L; Rimsza LM; Vose J; d'Amore F; Weisenburger DD; Chan WC; Iqbal J
Blood; 2022 Sep; 140(11):1278-1290. PubMed ID: 35639959
[TBL] [Abstract][Full Text] [Related]
20. Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study.
Piccaluga PP; Fuligni F; De Leo A; Bertuzzi C; Rossi M; Bacci F; Sabattini E; Agostinelli C; Gazzola A; Laginestra MA; Mannu C; Sapienza MR; Hartmann S; Hansmann ML; Piva R; Iqbal J; Chan JC; Weisenburger D; Vose JM; Bellei M; Federico M; Inghirami G; Zinzani PL; Pileri SA
J Clin Oncol; 2013 Aug; 31(24):3019-25. PubMed ID: 23857971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]